Cipla is a global pharmaceutical company with a legacy that spans almost 90 years. Driven by its founding philosophy of Caring for Life, Cipla's mission is to ensure that no patient is denied access to reliable treatment. This mission has made it a key figure in the fight against a number of diseases such as respiratory infections, HIV/AIDS, oncology, andrology, as well and men and women's health. By ensuring greater access to high-quality medicines, Cipla remains committed to its founding principles of bringing affordable healthcare to more people.
While the headquarters of Cipla is located in Mumbai, it operates a whole network of WHO and GMP certified manufacturing plants across the world. Its commitment to quality is emphasised by its state of the art research facilities and development of new and revolutionary treatments. By adhering to industry standards and following the strict protocols sets by the FDA office of generic drugs, Cipla has established itself as a market leader during its long and illustrious history.
Thanks to its strategic focus on key international markets, Cipla holds an extensive portfolio of more than 1,500 authorised products around the world. It famously revolutionized access to HIV/AIDS treatment but has now also shifted the focus towards helping men and women overcome sexually related challenges. The robust nature of Cipla's supply chain ensures a dependable flow of essential medicines to the healthcare industry in over 80 countries.
Cipla's impact on global healthcare over the last 8 decades can be attributed to its pioneering development of new treatments and its wide range of generic drugs. In the fight against sexually related challenges, treatments like Tadacip 20mg and Silagra have helped bring affordable and effective solutions to a greater number of men. Cipla's commitment to compliance and transparency has positioned itself as a pioneer and leader in the pharmaceutical industry.
